Retinoic acid induces nuclear accumulation of Raf1 during differentiation of HL-60 cells

Experimental Cell Research

Volumn 315, Issue 13, 2009, Pages 2241-2248

  Smith, James ^a   Bunaciu, Rodica P ^a   Reiterer, Gudrun ^a   Coder, David ^b   George, Thaddeus ^b   Asaly, Michael ^a   Yen, Andrew ^a  

^a Department of Obstetrics Gynecology   (United States)

^b Amnis Corporation   (United States)

Author keywords

All trans retinoic acid; HL 60; Leukemia; Nuclear Raf1

Indexed keywords

RAF PROTEIN; RAF1 PROTEIN; RETINOIC ACID; SERINE; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL STRAIN HL 60; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

EID: 67349284069     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.03.004     Document Type: Article

References (30)

1. Wang Z.Y., and Chen Z. Differentiation and apoptosis induction therapy in acute promyelocytic leukaemia. Lancet Oncol. 1 (2000) 101-106
2. Wang J., and Yen A. A MAPK-positive feedback mechanism for BLR1 signaling propels retinoic acid-triggered differentiation and cell cycle arrest. J. Biol. Chem. 283 (2008) 4375-4386
3. Reiterer G., and Yen A. Platelet-derived growth factor receptor regulates myeloid and monocytic differentiation of HL-60 cells. Cancer Res. 67 (2007) 7765-7772
4. Yen A., Roberson M.S., Varvayanis S., and Lee A.T. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res. 58 (1998) 3163-3172
5. Yen A., Cherington V., Schaffhausen B., Marks K., and Varvayanis S. Transformation-defective polyoma middle T antigen mutants defective in PLCgamma, PI-3, or src kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T. Exp. Cell Res. 248 (1999) 538-551
6. Yen A., Roberson M.S., and Varvayanis S. Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinases when inducing myeloid differentiation. In Vitro Cell. Dev. Biol., Anim. 35 (1999) 527-532
7. Yen A., Williams M., Platko J.D., Der C., and Hisaka M. Expression of activated RAF accelerates cell differentiation and RB protein down-regulation but not hypophosphorylation. Eur. J. Cell Biol. 65 (1994) 103-113
8. Tran N.H., and Frost J.A. Phosphorylation of Raf-1 by p21-activated kinase 1 and Src regulates Raf-1 autoinhibition. J. Biol. Chem. 278 (2003) 11221-11226
9. Oehrl W., Rubio I., and Wetzker R. Serine 338 phosphorylation is dispensable for activation of c-Raf1. J. Biol. Chem. 278 (2003) 17819-17826
10. Chong H., Vikis H.G., and Guan K.L. Mechanisms of regulating the Raf kinase family. Cell. Signal. 15 (2003) 463-469
11. Roberts P.J., and Der C.J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26 (2007) 3291-3310
12. Chow S., Hedley D., Grom P., Magari R., Jacobberger J.W., and Shankey T.V. Whole blood fixation and permeabilization protocol with red blood cell lysis for flow cytometry of intracellular phosphorylated epitopes in leukocyte subpopulations. Cytometry A 67 (2005) 4-17
13. Arechiga A.F., Bell B.D., Solomon J.C., Chu I.H., Dubois C.L., Hall B.E., George T.C., Coder D.M., and Walsh C.M. Cutting edge: FADD is not required for antigen receptor-mediated NF-kappaB activation. J. Immunol. 175 (2005) 7800-7804
14. George T.C., Fanning S.L., Fitzgeral-Bocarsly P., Medeiros R.B., Highfill S., Shimizu Y., Hall B.E., Frost K., Basiji D., Ortyn W.E., Morrissey P.J., and Lynch D.H. Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow. J. Immunol. Methods 311 (2006) 117-129
15. Ortyn W.E., Hall B.E., George T.C., Frost K., Basiji D.A., Perry D.J., Zimmerman C.A., Coder D., and Morrissey P.J. Sensitivity measurement and compensation in spectral imaging. Cytometry A 69 (2006) 852-862
16. Hong H.Y., Varvayanis S., and Yen A. Retinoic acid causes MEK-dependent RAF phosphorylation through RARalpha plus RXR activation in HL-60 cells. Differentiation 68 (2001) 55-66
17. Lamkin T.J., Chin V., Varvayanis S., Smith J.L., Sramkoski R.M., Jacobberger J.W., and Yen A. Retinoic acid-induced CD38 expression in HL-60 myeloblastic leukemia cells regulates cell differentiation or viability depending on expression levels. J. Cell. Biochem. 97 (2006) 1328-1338
18. Battle T.E., Levine R.A., and Yen A. Retinoic acid-induced blr1 expression promotes ERK2 activation and cell differentiation in HL-60 cells. Exp. Cell. Res. 254 (2000) 287-298
19. Wightman J., Roberson M.S., Lamkin T.J., Varvayanis S., and Yen A. Retinoic acid-induced growth arrest and differentiation: retinoic acid up-regulates CD32 (Fc gammaRII) expression, the ectopic expression of which retards the cell cycle. Mol. Cancer Ther. 1 (2002) 493-506
20. Yen A., Sturgill R., Varvayanis S., and Chern R. FMS (CSF-1 receptor) prolongs cell cycle and promotes retinoic acid-induced hypophosphorylation of retinoblastoma protein, G1 arrest, and cell differentiation. Exp. Cell. Res. 229 (1996) 111-125
21. Yen A., Sturgill R., and Varvayanis S. Increasing c-FMS (CSF-1 receptor) expression decreases retinoic acid concentration needed to cause cell differentiation and retinoblastoma protein hypophosphorylation. Cancer Res. 57 (1997) 2020-2028
22. Lamkin T.J., Chin V., and Yen A. All-trans retinoic acid induces p62DOK1 and p56DOK2 expression which enhances induced differentiation and G0 arrest of HL-60 leukemia cells. Am. J. Hematol. 81 (2006) 603-615
23. Yen A., Varvayanis S., Smith J.L., and Lamkin T.J. Retinoic acid induces expression of SLP-76: expression with c-FMS enhances ERK activation and retinoic acid-induced differentiation/G0 arrest of HL-60 cells. Eur. J. Cell. Biol. 85 (2006) 117-132
24. M. Shen, A. Yen, c-Cbl interacts with CD38 and promotes retinoic acid-induced differentiation and G0 arrest of human myeloblastic leukemia cells, Cancer Res. 68 (2008) 8761-8769.
25. Sasaki A., Taketomi T., Kato R., Saeki K., Nonami A., Sasaki M., Kuriyama M., Saito N., Shibuya M., and Yoshimura A. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Nat. Cell Biol. 5 (2003) 427-432
26. Jaggi F., Cabrita M.A., Perl A.K., and Christofori G. Modulation of endocrine pancreas development but not beta-cell carcinogenesis by Sprouty4. Mol. Cancer Res. 6 (2008) 468-482
27. Feng L., Xie X., Ding Q., Luo X., He J., Fan F., Liu W., Wang Z., and Chen Y. Spatial regulation of Raf kinase signaling by RKTG. Proc. Natl Acad. Sci. U. S. A. 104 (2007) 14348-14353
28. Fan F., Feng L., He J., Wang X., Jiang X., Zhang Y., Wang Z., and Chen Y. RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells. Carcinogenesis 29 (2008) 1157-1163
29. Kubicek M., Pacher M., Abraham D., Podar K., Eulitz M., and Baccarini M. Dephosphorylation of Ser-259 regulates Raf-1 membrane association. J. Biol. Chem. 277 (2002) 7913-7919
30. Kao S., Jaiswal R.K., Kolch W., and Landreth G.E. Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells. J. Biol. Chem. 276 (2001) 18169-18177